International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions

Publication Type:
Journal Article
Health Policy, 2009, 89 (3), pp. 252 - 260
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2007003251OK.pdf201.51 kB
Adobe PDF
To examine and evaluate the economic evidence regarding the use of tandem mass spectrometry (MS/MS) for the detection of rare metabolic conditions in neonates, and then to consider the transferability of these national-level results to other decision-making contexts. Methods A systematic literature review was undertaken, identifying papers published between January 1997 and March 2008. Thirteen unique cost-effectiveness evaluations were identified and appraised for comparability and transferability of results across settings.
Please use this identifier to cite or link to this item: